Medpace Holdings, Inc. Share Price Today: Live Updates & Key Insights

Medpace Holdings, Inc. share price today is $453.87, up -1.82%. The stock opened at $464.6 against the previous close of $460.92, with an intraday high of $464.6 and low of $449.66.

Medpace Holdings, Inc. Share Price Chart

Medpace Holdings, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Medpace Holdings, Inc. Share Price Performance

$453.87 -0.0182(-1.82%) MEDP at 23 Mar 2026 02:14 PM Diagnostics & Research
Lowest Today 449.66
Highest Today 464.6
Today’s Open 464.6
Prev. Close 460.92
52 Week High 628.92
52 Week Low 250.05
Day’s Range: Low 449.66 High 464.6
52-Week Range: Low 250.05 High 628.92
1 day return -
1 Week return -0.13
1 month return +1.7
3 month return -20.78
6 month return -9.08
1 year return +37.32
3 year return +153.16
5 year return +175.41
10 year return -

Medpace Holdings, Inc. Institutional Holdings

BlackRock Inc 8.31

Vanguard Group Inc 7.97

AQR Capital Management LLC 4.76

iShares Core S&P Mid-Cap ETF 2.53

Vanguard Total Stock Mkt Idx Inv 2.50

State Street Corp 2.37

Geode Capital Management, LLC 2.35

Wasatch Advisors LP 2.28

Baillie Gifford & Co Limited. 1.93

Amvescap Plc. 1.89

D. E. Shaw & Co LP 1.86

Morgan Stanley - Brokerage Accounts 1.80

Vanguard Small Cap Index 1.80

Renaissance Technologies Corp 1.64

Mawer Investment Management Ltd 1.44

Arrowstreet Capital Limited Partnership 1.32

Dimensional Fund Advisors, Inc. 1.27

JPMorgan Chase & Co 1.25

Invesco S&P MidCap Quality ETF 1.13

Bessemer Group Inc 1.12

Vanguard Small Cap Growth Index Inv 1.00

Madison Asset Management, LLC 0.98

Riverbridge Partners LLC 0.96

Giverny Capital Inc. 0.93

ClearBridge Advisors, LLC 0.90

Vanguard Institutional Extnd Mkt Idx Tr 0.85

Vanguard Explorer Inv 0.74

TD Global Capital Reinvestment - I 0.62

Findlay Park American I USD Dist 0.61

Wasatch Core Growth 0.60

iShares Biotechnology ETF 0.60

State Street® SPDR® S&P MIDCAP 400® ETF 0.57

iShares Russell Mid-Cap Growth ETF 0.53

TD U.S. Capital Reinvestment I 0.49

Pacer US Large Cp CA Cows Gr Ldrs ETF 0.48

Madison Mid Cap Y 0.47

State St Russell Sm/Mid Cp® Indx SL Cl I 0.46

Smithson Investment Trust Ord 0.45

iShares S&P Mid-Cap 400 Growth ETF 0.43

Fidelity Extended Market Index 0.41

Medpace Holdings, Inc. Market Status

Strong Buy: 2

Buy: 0

Hold: 10

Sell: 0

Strong Sell: 0

Medpace Holdings, Inc. Fundamentals

Market Cap 12842.82 M

PB Ratio 28.4956

PE Ratio 29.5952

Enterprise Value 12698.09 M

Total Assets 1975.47 M

Volume 581297

Medpace Holdings, Inc. Company Financials

Annual Revenue FY25:2530234000 2530.2M, FY24:2109054000 2109.1M, FY23:1781539000 1781.5M, FY22:1459996000 1460.0M, FY21:1142377000 1142.4M

Annual Profit FY25:760618000 760.6M, FY24:656305000 656.3M, FY23:503430000 503.4M, FY22:432438000 432.4M, FY21:328155000 328.2M

Annual Net worth FY25:451123000 451.1M, FY24:404386000 404.4M, FY23:273182000 273.2M, FY22:245368000 245.4M, FY21:181848000 181.8M

Quarterly Revenue Q4/2025:708450000 708.5M, Q3/2025:659903000 659.9M, Q2/2025:603311000 603.3M, Q1/2025:558570000 558.6M, Q4/2024:536589000 536.6M

Quarterly Profit Q4/2025:205316000 205.3M, Q3/2025:196939000 196.9M, Q2/2025:180013000 180.0M, Q1/2025:178350000 178.4M, Q4/2024:178317000 178.3M

Quarterly Net worth Q4/2025:135133000 135.1M, Q3/2025:111135000 111.1M, Q2/2025:90260000 90.3M, Q1/2025:114595000 114.6M, Q4/2024:117018000 117.0M

About Medpace Holdings, Inc. & investment objective

Company Information Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Organisation Diagnostics & Research

Employees 6200

Industry Diagnostics & Research

CEO Dr. August James Troendle M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Medpace Holdings, Inc. FAQs

What is the share price of Medpace Holdings, Inc. today?

The current share price of Medpace Holdings, Inc. is $453.87.

Can I buy Medpace Holdings, Inc. shares in India?

Yes, Indian investors can buy Medpace Holdings, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Medpace Holdings, Inc. shares in India?

You can easily invest in Medpace Holdings, Inc. shares from India by:

Can I buy fractional shares of Medpace Holdings, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Medpace Holdings, Inc.?

Medpace Holdings, Inc. has a market cap of $12842.82 M.

In which sector does Medpace Holdings, Inc. belong?

Medpace Holdings, Inc. operates in the Diagnostics & Research sector.

What documents are required to invest in Medpace Holdings, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Medpace Holdings, Inc.?

The PE ratio of Medpace Holdings, Inc. is 29.60 and the PB ratio is 28.50.